Ticker: KROS

Company: Keros Therapeutics, Inc.

Person: BIENAIME JEAN JACQUES, director

Transaction date: Aug. 17, 2026

Reporting date: Aug. 19, 2026

Average share price: 10.27

Bought 1000.0 shares for 10270.0